Comparison of OPPO Watch Sleep Analyzer and Polysomnography for Obstructive Sleep Apnea Screening
Guangxin Zhou,Wei Zhao,Yi Zhang,Wenli Zhou,Haizhou Yan,Yongli Wei,Yuming Tang,Zijing Zeng,Hanrong Cheng
DOI: https://doi.org/10.2147/nss.s438065
2024-02-09
Nature and Science of Sleep
Abstract:Guangxin Zhou, 1, 2 Wei Zhao, 2 Yi Zhang, 2 Wenli Zhou, 2 Haizhou Yan, 2 Yongli Wei, 1 Yuming Tang, 1 Zijing Zeng, 2 Hanrong Cheng 1 1 Department of Sleep Medicine, Institute of Respiratory Diseases, Shenzhen People's Hospital, The Second Clinical Medical College of Jinan University, The First Affiliated Hospital of Southern University of Science and Technology, Shenzhen, Guangdong, People's Republic of China; 2 OPPO Health, Guangdong OPPO Mobile Telecommunications Co. Ltd., Shenzhen, Guangdong, People's Republic of China Correspondence: Hanrong Cheng, Department of Sleep Medicine, Shenzhen People's Hospital, The Second Clinical Medical College of Jinan University, The First Affiliated Hospital of Southern University of Science and Technology, Shenzhen, Guangdong, People's Republic of China, Email Objective: To evaluate the clinical performance of the OPPO Watch (OW) Sleep Analyzer (OWSA) on OSA screening with polysomnography reference. Methods: We recruited 350 participants using OWSA and PSG simultaneously in a sleep laboratory. The respiratory event index (REI) derived from OWSA and the apnea-hypopnea index (AHI) provided by PSG were compared. SHapley Additive exPlanation (SHAP) values were calculated to explain the model of OWSA. Results: The OWSA-REI (26.5± 18.5 events/h) correlated well with PSG-AHI (33.2± 25.7 events/h; r = 0.91, p < 0.001), with an intraclass correlation coefficient (ICC) of 0.83. Using a threshold of AHI ≥ 15 events/h, the sensitivity, specificity, accuracy, and area under the curve (AUC) were 86.1%, 86.7%, 86.3%, and 0.94, respectively. Bland-Altman analysis showed that OWSA-REI and PSG-AHI were in good agreement (Mean Difference: − 6.7, 95% CI:16.0 to − 29.3 events/h). In addition, the effectiveness of the models in OWSA were also explained by visualizing SHAP values. Conclusion: The OWSA demonstrated a reasonable performance for OSA screening in the clinical setting. In light of this, it is possible for smartwatches to become a complementary tool to PSG, which is particularly useful for larger-scale preliminary screenings. Plain Language Summary: OPPO Watch Sleep Analyzer (OWSA), an emerging sleep-tracking method based on a wearable device, uses a machine learning model to analyze physiological signals including snoring recordings, and other basic anthropometric information to estimate REI. The study evaluated the OSA screening performance of OWSA with PSG-AHI and interpreted the results of the pre-trained machine learning model. OWSA demonstrated consistent clinical diagnostic performance for OSA. The interpretive machine learning models used in OWSA highlighted the impact of multi-modal data on estimation results. Therefore, these types of models are likely to be more widely accepted and promoted in clinical practice. Keywords: obstructive sleep apnea, photoplethysmography, polysomnography, smartwatch Sleep is a critical part of daily life and plays an essential role in our immune, cardiovascular, and neurocognitive systems. 1 Sleep quality can be affected by lifestyles, mental health conditions, and many pathophysiological conditions, such as restless legs syndrome, sleep apnea-hypopnea syndrome (SAHS), and Cheyne-Stokes breathing. Among these, SAHS is a risk factor for other chronic conditions, such as hypertension, diabetes, and stroke, and it is also associated with sudden death and road traffic accidents. 2 Obstructive Sleep Apnea (OSA) is the most common type of SAHS, accounting for more than 80% of cases. There are currently 936 million adults aged 30 to 69 years worldwide with mild to severe OSA and 425 million adults aged 30 to 69 years with moderate to severe OSA. 3 China has 176 million people affected by OSA, which is the highest number compared to the world's average. 3 OSA severely affects sleep, as the main symptoms of OSA are loud snoring, mouth breathing, easy waking up, etc. The gold standard for the diagnosis of OSA is overnight in-lab polysomnography (PSG), which monitors electroencephalogram (EEG), electrooculography (EOG), electromyography (EMG), electrocardiogram (ECG), nasal pressure, airflow (AF), the respiratory effort of chest and abdomen, snoring, etc. Moreover, there are many issues with the widely-adopted PSG. For example, wearing complicated PSG makes participants difficult to fall asleep, and the cost of PSG is relatively high for families with low to ordinary income. Furthermore, the data collected during a whole night PSG test needs to be scored by trained technicians according to the American Academy of Sleep Medicine (AASM) standards. The consistency of PSG event an -Abstract Truncated-
neurosciences,clinical neurology